Carbetocin

卡贝缩宫素

Report date: 2025/09/25 14:40:14
NME

Base Information

Drug NameCarbetocin
Drug Alias NameCarbetocinumCarbetocinaPabalDuratobalDuratocin +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOxytocin receptor agonists
TargetsOxytocin receptor
Therapy Area/IndicationsHyperphagiaObesityPostpartum Hemorrhage
Global Approved IndicationsPostpartum Hemorrhage
Approved Indications in ChinaPostpartum Hemorrhage
Original Approved Country/TerritoryN/A
Original Approved Date1984/01/01
Country/TerritoryUnited StatesBangladeshEgypt +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesFerring Bv
China Registration ClassN/A

Develop Information

Active CompaniesCairo UniversityFerring BvJubilant Hollisterstier General Partnership +[4] 
Inactive CompaniesBangabandhu Sheikh Mujib Medical University
Active IndicationsObesityPostpartum Hemorrhage
Inactive IndicationsHyperphagia

Other Information

ATC CodeH01BB03
Related LinksWikipediaDrugBankKEGG